About Biomed Realty Trust (NYSE:BMR)
BioMed Realty Trust, Inc. operates as a real estate investment trust (REIT). The Company is the parent company and general partner of BioMed Realty, L.P. The Company owns, acquires, develops, redevelops, leases and manages laboratory and office space for the life science industry. The Company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. The Company's properties are located in markets, which has centers for scientific research, including Boston, San Francisco, San Diego, Maryland, New York, New Jersey, Pennsylvania, North Carolina, Seattle, Cambridge (the United Kingdom) and research parks located near or adjacent to universities and their related medical systems. The Company owns interests in properties comprising approximately 17.5 million rentable square feet.
Industry, Sector and Symbol
Industry Commercial REITs
Trailing P/E Ratio22.8942307692308
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on Equity3.73%
Return on Assets2.07%
Biomed Realty Trust (NYSE:BMR) Frequently Asked Questions
What is Biomed Realty Trust's stock symbol?
Biomed Realty Trust trades on the New York Stock Exchange (NYSE) under the ticker symbol "BMR."
How were Biomed Realty Trust's earnings last quarter?
Biomed Realty Trust Inc (NYSE:BMR) issued its quarterly earnings results on Tuesday, April, 28th. The real estate investment trust reported $0.41 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.37 by $0.04. The real estate investment trust had revenue of $178.01 million for the quarter, compared to analyst estimates of $167.08 million. Biomed Realty Trust had a net margin of 18.98% and a return on equity of 3.73%. Biomed Realty Trust's revenue for the quarter was up 5.4% compared to the same quarter last year. During the same quarter in the prior year, the business posted $0.38 EPS. View Biomed Realty Trust's Earnings History.
Who are some of Biomed Realty Trust's key competitors?
Some companies that are related to Biomed Realty Trust include Digital Realty Trust (DLR), Realty Income (O), Vornado Realty Trust (VNO), Alexandria Real Estate Equities (ARE), Federal Realty Investment Trust (FRT), Kilroy Realty (KRC), Vereit (VER), British Land (BLND), Douglas Emmett (DEI), DuPont Fabros Technology (DFT), Liberty Property Trust (LPT), Store Capital (STOR), Equity One (EQY), EPR Properties (EPR), Hammerson (HMSO), Cousins Properties (CUZ), Derwent London (DLN) and PS Business Parks (PSB).
Who are Biomed Realty Trust's key executives?
Biomed Realty Trust's management team includes the folowing people:
- Greg N. Lubushkin, Chief Financial Officer (Age 62)
- James R. Berens, President of Wexford Science & Technology (Age 61)
- Jonathan Paul Klassen, Executive Vice President, General Counsel, Secretary (Age 39)
- John P. Bonanno, Executive Vice President, Leasing & Development (Age 49)
- Karen A. Sztraicher, Executive Vice President - Asset Management (Age 51)
How do I buy Biomed Realty Trust stock?
Shares of Biomed Realty Trust can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How can I contact Biomed Realty Trust?
Biomed Realty Trust's mailing address is 17190 Bernardo Center Dr, SAN DIEGO, CA 92128-7030, United States. The real estate investment trust can be reached via phone at +1-858-4859840.
MarketBeat Community Rating for Biomed Realty Trust (BMR)MarketBeat's community ratings are surveys of what our community members think about Biomed Realty Trust and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Biomed Realty Trust (NYSE:BMR) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Biomed Realty Trust (NYSE:BMR) Earnings History and Estimates Chart
Biomed Realty Trust (NYSE BMR) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|11/5/2015||Q3 2015||$0.39||$0.14||$167.23 million||$174.35 million||View||N/A|
|7/28/2015||Q2 2015||$0.46||$0.11||$159.42 million||$157.97 million||View||N/A|
|4/28/2015||Q115||$0.37||$0.41||$167.08 million||$178.01 million||View||Listen|
|2/4/2015||Q4 2014||$0.36||$0.70||$164.79 million||$165.66 million||View||N/A|
|10/29/2014||Q3 2014||$0.37||$0.08||$164.89 million||$168.92 million||View||N/A|
|8/5/2014||Q214||$0.36||$0.40||$160.80 million||$171.16 million||View||Listen|
|4/30/2014||Q1 2014||$0.35||$0.10||$159.69 million||$168.88 million||View||N/A|
|2/5/2014||Q4 2013||$0.33||$0.05||$157.73 million||$157.99 million||View||N/A|
|11/5/2013||Q3 2013||$0.33||$0.02||$146.29 million||$159.23 million||View||N/A|
|8/7/2013||Q213||$0.39||$0.37||$143.47 million||$159.64 million||View||Listen|
|5/1/2013||Q1 2013||$0.38||$0.05||$142.50 million||$160.45 million||View||N/A|
|2/6/2013||Q412||$0.34||$0.36||$134.72 million||$138.80 million||View||Listen|
|11/1/2012||Q312||$0.33||$0.34||$130.32 million||$134.54 million||View||N/A|
Biomed Realty Trust (NYSE:BMR) Earnings Estimates
No earnings estimates for this company have been tracked by MarketBeat.com
Biomed Realty Trust (NYSE:BMR) Dividend Information
|Most Recent Dividend:||10/15/2015|
|Dividend Growth:||0.00% (3 Year Average)|
|Payout Ratio:||100.00% (Trailing 12 Months of Earnings) |
Biomed Realty Trust (NYSE:BMR) Dividend History by Quarter
(Data available from 1/1/2013 forward)
|Announced||Period||Amount||Yield||Ex-Dividend Date||Record Date||Payable Date|
Biomed Realty Trust (NYSE BMR) Insider Trading and Institutional Ownership History
Biomed Realty Trust (NYSE BMR) Insider Trades by Quarter
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Shares Held After Transaction||Details|
|8/17/2015||John P Bonanno||EVP||Sell||4,800||$21.01||$100,848.00|| |
|6/15/2015||James R Berens||Insider||Sell||2,000||$19.99||$39,980.00|| |
|6/15/2015||John P Bonanno||EVP||Sell||5,000||$19.85||$99,250.00|| |
|3/16/2015||Margaret Faye Wilson||Director||Buy||2,300||$21.76||$50,048.00|| |
|9/8/2014||Stephen A Willey||CAO||Sell||1,388||$22.50||$31,230.00|| |
|8/13/2014||Alan D Gold||CEO||Sell||26,615||$22.17||$590,054.55|| |
|8/13/2014||Matthew G Mcdevitt||VP||Sell||16,000||$22.01||$352,160.00|| |
|6/3/2014||Matthew G Mcdevitt||VP||Sell||7,000||$21.91||$153,370.00|| |
|5/14/2014||Alan Gold||CEO||Sell||25,000||$21.18||$529,500.00||459,177|| |
|5/12/2014||Stephen Willey||CAO||Sell||4,840||$21.00||$101,640.00||22,560|| |
|3/11/2014||Stephen Willey||CAO||Sell||7,931||$20.25||$160,602.75||27,400|| |
|2/11/2014||Matthew Mcdevitt||VP||Sell||60,000||$20.28||$1,216,800.00||145,328|| |
|11/23/2012||Matthew G Mcdevitt||VP||Sell||5,223||$19.05||$99,498.15|| |
Biomed Realty Trust (NYSE BMR) News Headlines
Biomed Realty Trust (NYSE:BMR) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Biomed Realty Trust (NYSE:BMR) Income Statement, Balance Sheet and Cash Flow Statement
Biomed Realty Trust (NYSE BMR) Stock Chart for Wednesday, February, 21, 2018